Summary of Product Characteristics
last updated on the eMC:
05/06/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 05/06/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 6. 3 - Shelf Life
|
| Date of revision of text on the SPC: 01-Dec-2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| NeoMercazole 5 mg Tablets-reduction in the shelf life of the product from 5 years to 3 years. No change to 20 mg.
|
|
Updated on 10/03/2008 and displayed until 05/06/2009
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 12/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 4.8 (undersirable effect) added of loss of taste to this section
|
|
Updated on 25/09/2007 and displayed until 10/03/2008
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 29/06/2004 and displayed until 25/09/2007
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|
